Yes.
A U.S. Food and Drug Administration advisory panel voted 11 to 3 to recommend the approval of an OTC formulation of orlistat, to be marketed under the name alli by GlaxoSmithKline. Approval was granted on February 7, 2007, and alli became the first weight loss drug officially sanctioned by the U.S. government for over-the-counter use. Consumer advocacy organization Health Research Group, opposed over-the-counter approval for orlistat, calling it "a dangerous mistake" due to questionable benefits and possible adverse effects. Becoming available in the U.S. during the summer of 2007, alli will be sold as 60 mg capsules — half the dosage of prescription orlistat.

see full Orlistat alli and Xenical diet pill review here